• Global Locations
• Site Map
• Home

• About Us
  • Corporate Profile
  • Company History
  • Management Team
  • Corporate Alliances
  • Intellectual Property
• Focus Markets
  • Focus Markets Overview
  • Surgical
  • Specialty OEM
  • Specialties Ophthalmology
  • Specialties Dental
  • Specialties Microsurgery
  • Private Label
• Technology
  • Technology Pipeline
  • Clinical Trials
• Investors
  • Investor Overview
  • Corporate Governance
  • Events & Webcasts
  • Quarterly Results
  • Proxy Materials
  • SEC Filings
  • Covering Analysts
  • Request Information
• News
  • Press Releases
  • Email Alerts
• Careers
• Contact Us

 Investor Overview

This information is intended for investors. Please read our website's Terms of Use.

Welcome to Angiotech's Investor Relations section. Use the navigation menu on the left to find up-to-date corporate financial information. Some other helpful links include:

• Earnings Reports
• Events and Webcasts
• Company Information
• News Releases

Important Financial Release Dates 2009

• Q1 : Thursday, April 30
• Q2 : TBD
• Q3 : TBD
• Q4 : TBD

Investor Relations Contacts

Investors, security analysts and representatives of portfolio management firms may contact:

DeDe Sheel
tel: (415) 293-4412
Or, email Investor Relations at ir@angio.com

Communication regarding transfer requirements, lost certificates and changes of address should be directed to:

Computershare Trust Co. of Canada
510 Burrard Street
Vancouver, BC CANADA
V6C 3B9
tel: (604)661-9400
www.computershare.com

Investors

• Investor Overview
• Corporate Governance
  • Board Members - Biographies
• Events & Webcasts
  • Events Archive
• Quarterly Results
• Proxy Materials
• SEC Filings
• Covering Analysts
• Request Information

Quick Links

• Events & Webcasts
• Latest Quarterly Results
• Press Releases
• Annual Reports

• Terms of Use
• Privacy Policy

© Copyright 2006. All Rights Reserved.